This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Molina Healthcare Chooses Elsevier's MEDai Analytics To Manage Medicaid Population Health

Stocks in this article: ENL RUK

ORLANDO, Florida, March 26, 2013 /PRNewswire/ --

One of the largest Medicaid health plans in the U.S. looks to Elsevier's MEDai to help control costs, coordinate care and improve the health of its member population

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced successful implementation of a three-year analytics software licensing contract with Molina Healthcare, Inc., of Long Beach, CA. Molina Healthcare, a Fortune 500 company, is a leader in providing quality healthcare for financially vulnerable individuals and families.

Molina Healthcare selected Elsevier's MEDai Navigator, which will help Molina manage its Medicaid populations across nine states, totaling more than 1.8 million people. Predictive and clinical analytics will be an essential tool to create targeted programs to help identify high-risk members, track healthcare metrics against benchmarks, and provide care managers with access to current clinical and financial data.

"We believe that Elsevier's analytic solutions will support our focus on member and clinician engagements and improve measurement and quality of care for our members," said Richard Sanchez, MD, Chief Medical Officer, Molina Healthcare. "We need a comprehensive, reliable solution and are confident we have found it with MEDai Navigator."

MEDai Navigator is able to analyze Molina's Medicaid population state-by-state and perform mapping, formatting and intelligent data clean-up and analytic modeling. Molina chose MEDai Navigator because of its ease-of-use, reliability and transparency of risk predictions, integration of evidence-based medicine guidelines, and the speed and thoroughness of solution implementation.

"We are pleased to be working with Molina and assisting them in turning membership data into actionable information that can be used to improve quality, deliver better outcomes in care and reduce costs through analytical modeling," said Peter Edelstein, M.D., Vice President and Chief Medical Officer for Elsevier's MEDai. "Both Molina Healthcare and Elsevier believe that this relationship translates into better health care for the many members managed by Molina."

For more information, please visit or call +1-866-422-5156.

About Elsevier

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs